Cell Therapy - Falling short of its potential?

<p>Despite major investment in the field, few cell therapies have gained regulatory approval with limited commercial success.</p> <p>The success of therapeutic products is defined by three factors: safety, efficacy and scalability. Achieving these for cell therapy presents new challenges; overcoming transplant rejection (and GvHD in the case of immune cells), producing and culturing functional cells and developing an off-the-shelf therapy with a scalable manufacturing process.</p> <p><strong>If you'd like to view the original article then follow the link below:</strong></p> <p><a href= "https://www.ddw-online.com/therapeutics/p323014-cell-therapy-falling-short-of-its-potential.html"> https://www.ddw-online.com/therapeutics/p323014-cell-therapy-falling-short-of-its-potential.html</a></p> <p><strong>You can also download the original article pdf here:</strong></p> <p><a href= "https://www.ddw-online.com/media/32/136359/(6)-cell-therapy.pdf">https://www.ddw-online.com/media/32/136359/(6)-cell-therapy.pdf</a></p> <p><strong>For more information on Drug Discovery World, head to:</strong></p> <p><a href= "https://www.ddw-online.com">https://www.ddw-online.com</a></p>